Publications

You are here

Home » Technology Platforms

Listed below are the Publications supported by Technology platforms at C-CAMP / Bangalore Life Science Cluster.

Export 7 results:
Author Title Type [ Year(Desc)]
Filters: Author is Pal, Rajarshi  [Clear All Filters]
2018
Surendran H, Rathod RJ, Pal R.  2018.  Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD). [Eyestem, a C-CAMP Startup]. Methods Mol Biol.
2019
Surendran H, Rajamoorthy M, Pal R.  2019.  Differentiating Human Induced Pluripotent Stem Cells (iPSCs) Into Lung Epithelial Cells. [Eyestem, a C-CAMP Startup]. Curr Protoc Stem Cell Biol. :e86.
2020
Surendran H, Nandakumar S, Pal R.  2020.  Human induced pluripotent stem cell-derived lung epithelial system for SARS-CoV-2 infection modeling and its potential in drug repurposing [Eyestem Research Pvt. Ltd., a C-CAMP Startup]. Stem Cells Dev.
2021
Konala VBhaskar Re, Nandakumar S, Surendran H, Pal R.  2021.  Derivation of Induced Pluripotent Stem Cell (iPSC) Lines from Patient-Specific Peripheral Blood Mononuclear Cells (PBMC) Using Episomal Vectors [Eyestem Research Pvt. Ltd., a C-CAMP Startup]. Methods Mol Biol.
Nandakumar S, Shahani P, Datta I, Pal R.  2021.  Interventional Strategies for Parkinson Disease: Can Neural Precursor Cells Forge a Path Ahead? [Eyestem Research, a C-CAMP startup] ACS Chemical Neuroscience.
Surendran H, Nandakumar S, K VBhaskar Re, Stoddard J, K VMohan, Upadhyay PK, McGill TJ, Pal R.  2021.  Transplantation of retinal pigment epithelium and photoreceptors generated concomitantly via small molecule-mediated differentiation rescues visual function in rodent models of retinal degeneration [Eyestem Research Pvt. Ltd., a C-CAMP Startup]. Stem Cell Res Ther. 12(1):70.
2022
Surendran H, Kumar S, Narasimhaiah S, Ananthamurthy A, Varghese PS, D'Souza GA, Medigeshi G, Pal R.  2022.  SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways [Eyestem Research Pvt. Ltd., a C-CAMP Startup]. J Cell Physiol.